Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Retained Earnings (2021 - 2025)

LifeStance Health (LFST) has disclosed Retained Earnings for 5 consecutive years, with $345000.0 as the latest value for Q2 2025.

  • On a quarterly basis, Retained Earnings fell 86.95% to $345000.0 in Q2 2025 year-over-year; TTM through Jun 2025 was $345000.0, a 86.95% decrease, with the full-year FY2024 number at -$818.3 million, down 7.55% from a year prior.
  • Retained Earnings was $345000.0 for Q2 2025 at LifeStance Health, down from $612000.0 in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $4.2 million in Q2 2023 to a low of -$818.3 million in Q4 2024.
  • A 5-year average of -$310.5 million and a median of -$249.0 million in 2021 define the central range for Retained Earnings.
  • Peak YoY movement for Retained Earnings: soared 101.28% in 2022, then crashed 39119.11% in 2024.
  • LifeStance Health's Retained Earnings stood at -$357.1 million in 2021, then plummeted by 60.37% to -$572.6 million in 2022, then tumbled by 32.87% to -$760.8 million in 2023, then fell by 7.55% to -$818.3 million in 2024, then surged by 100.04% to $345000.0 in 2025.
  • Per Business Quant, the three most recent readings for LFST's Retained Earnings are $345000.0 (Q2 2025), $612000.0 (Q1 2025), and -$818.3 million (Q4 2024).